Choice of biologic drug among children with juvenile idiopathic arthritis.

about

Choice of biologic drug among children with juvenile idiopathic arthritis.

Item

http://www.wikidata.org/entity/Q54573196

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Choice of biologic drug among children with juvenile idiopathic arthritis.

@en

Choice of biologic drug among children with juvenile idiopathic arthritis.

@nl

type

Item

label

Choice of biologic drug among children with juvenile idiopathic arthritis.

@en

Choice of biologic drug among children with juvenile idiopathic arthritis.

@nl

prefLabel

Choice of biologic drug among children with juvenile idiopathic arthritis.

@en

Choice of biologic drug among children with juvenile idiopathic arthritis.

@nl

P1476

Choice of biologic drug among children with juvenile idiopathic arthritis.

@en

P2860

The majority of newly diagnosed patients with juvenile idiopathic arthritis reach an inactive disease state within the first year of specialised care: data from a German inception cohort

Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis.

A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)

Biological treatment in systemic juvenile idiopathic arthritis: achievement of inactive disease or clinical remission on a first, second or third biological agent.

Time to share.

Factors associated with choice of biologic among children with Juvenile Idiopathic Arthritis: results from two UK paediatric biologic registers.

Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis.

Trends in prescription of biological agents and outcomes of juvenile idiopathic arthritis: results of the Dutch national Arthritis and Biologics in Children Register.

It is time to rethink juvenile idiopathic arthritis classification and nomenclature.

P304

1534-1535

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1093/RHEUMATOLOGY/KEW209

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Pierre Quartier

P577

2016-05-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27170598

http://www.w3.org/2001/XMLSchema#string

P921

juvenile rheumatoid arthritis